Experiment: 2MSG

SOLID-STATE NMR

NMR Experiment
Experiment	Type	Sample Contents	Solvent	Ionic Strength	pH	Pressure	Temperature (K)	Spectrometer
1	PDSD	20 mg [U-100% 13C; U-100% 15N] Ubiquitin, 30 mg [1-glucose 13C,U-100% 15N] Ubiquitin, 40 mg [2-glucose 13C,U-100% 15N] Ubiquitin, 40 % v/v MPD, 0.2 M CdCl2, 1 mg DSS	100% H20			ambient	273
2	PDSD	20 mg [U-100% 13C; U-100% 15N] Ubiquitin, 30 mg [1-glucose 13C,U-100% 15N] Ubiquitin, 40 mg [2-glucose 13C,U-100% 15N] Ubiquitin, 40 % v/v MPD, 0.2 M CdCl2, 1 mg DSS	100% H20			ambient	273
3	NCA	20 mg [U-100% 13C; U-100% 15N] Ubiquitin, 30 mg [1-glucose 13C,U-100% 15N] Ubiquitin, 40 mg [2-glucose 13C,U-100% 15N] Ubiquitin, 40 % v/v MPD, 0.2 M CdCl2, 1 mg DSS	100% H20			ambient	273
4	NCO	20 mg [U-100% 13C; U-100% 15N] Ubiquitin, 30 mg [1-glucose 13C,U-100% 15N] Ubiquitin, 40 mg [2-glucose 13C,U-100% 15N] Ubiquitin, 40 % v/v MPD, 0.2 M CdCl2, 1 mg DSS	100% H20			ambient	273
5	INEPT	20 mg [U-100% 13C; U-100% 15N] Ubiquitin, 30 mg [1-glucose 13C,U-100% 15N] Ubiquitin, 40 mg [2-glucose 13C,U-100% 15N] Ubiquitin, 40 % v/v MPD, 0.2 M CdCl2, 1 mg DSS	100% H20			ambient	273
6	NCACX	20 mg [U-100% 13C; U-100% 15N] Ubiquitin, 30 mg [1-glucose 13C,U-100% 15N] Ubiquitin, 40 mg [2-glucose 13C,U-100% 15N] Ubiquitin, 40 % v/v MPD, 0.2 M CdCl2, 1 mg DSS	100% H20			ambient	273
7	NCOCX	20 mg [U-100% 13C; U-100% 15N] Ubiquitin, 30 mg [1-glucose 13C,U-100% 15N] Ubiquitin, 40 mg [2-glucose 13C,U-100% 15N] Ubiquitin, 40 % v/v MPD, 0.2 M CdCl2, 1 mg DSS	100% H20			ambient	273
8	PDSD	20 mg [U-100% 13C; U-100% 15N] Ubiquitin, 30 mg [1-glucose 13C,U-100% 15N] Ubiquitin, 40 mg [2-glucose 13C,U-100% 15N] Ubiquitin, 40 % v/v MPD, 0.2 M CdCl2, 1 mg DSS	100% H20			ambient	273
9	PDSD	20 mg [U-100% 13C; U-100% 15N] Ubiquitin, 30 mg [1-glucose 13C,U-100% 15N] Ubiquitin, 40 mg [2-glucose 13C,U-100% 15N] Ubiquitin, 40 % v/v MPD, 0.2 M CdCl2, 1 mg DSS	100% H20			ambient	273
10	PDSD	20 mg [U-100% 13C; U-100% 15N] Ubiquitin, 30 mg [1-glucose 13C,U-100% 15N] Ubiquitin, 40 mg [2-glucose 13C,U-100% 15N] Ubiquitin, 40 % v/v MPD, 0.2 M CdCl2, 1 mg DSS	100% H20			ambient	273
11	NCA	20 mg [U-100% 13C; U-100% 15N] Ubiquitin, 30 mg [1-glucose 13C,U-100% 15N] Ubiquitin, 40 mg [2-glucose 13C,U-100% 15N] Ubiquitin, 40 % v/v MPD, 0.2 M CdCl2, 1 mg DSS	100% H20			ambient	273
12	PDSD	20 mg [U-100% 13C; U-100% 15N] Ubiquitin, 30 mg [1-glucose 13C,U-100% 15N] Ubiquitin, 40 mg [2-glucose 13C,U-100% 15N] Ubiquitin, 40 % v/v MPD, 0.2 M CdCl2, 1 mg DSS	100% H20			ambient	273
13	PDSD	20 mg [U-100% 13C; U-100% 15N] Ubiquitin, 30 mg [1-glucose 13C,U-100% 15N] Ubiquitin, 40 mg [2-glucose 13C,U-100% 15N] Ubiquitin, 40 % v/v MPD, 0.2 M CdCl2, 1 mg DSS	100% H20			ambient	273
14	PDSD	20 mg [U-100% 13C; U-100% 15N] Ubiquitin, 30 mg [1-glucose 13C,U-100% 15N] Ubiquitin, 40 mg [2-glucose 13C,U-100% 15N] Ubiquitin, 40 % v/v MPD, 0.2 M CdCl2, 1 mg DSS	100% H20			ambient	273
15	NCA	20 mg [U-100% 13C; U-100% 15N] Ubiquitin, 30 mg [1-glucose 13C,U-100% 15N] Ubiquitin, 40 mg [2-glucose 13C,U-100% 15N] Ubiquitin, 40 % v/v MPD, 0.2 M CdCl2, 1 mg DSS	100% H20			ambient	273

NMR Spectrometer Information
Spectrometer	Manufacturer	Model	Field Strength
1	Bruker	AVANCE	800
2	Bruker	AVANCE	850
3	Bruker	AVANCE	600

NMR Refinement
Method	Details	Software
torsion angle dynamics		X-PLOR NIH

NMR Ensemble Information
Conformer Selection Criteria	structures with the lowest energy
Conformers Calculated Total Number	1000
Conformers Submitted Total Number	10
Representative Model	1 (minimized average structure)

Additional NMR Experimental Information
Details	three different labeled samples Ubiquitin-unif [13C-15N] uniformly labeled Ubiquitin-1glc [13C-15N]-1glucose labeled Ubiquitin-2glu [13C-15N]-2glucose labeled

Computation: NMR Software
#	Classification	Version	Software Name	Author
1	processing	X-PLOR NIH	2.36	Bruker Biospin
2	chemical shift assignment	X-PLOR NIH	2.36	Bruker Biospin
3	data analysis	X-PLOR NIH	2.36	Bruker Biospin
4	refinement	X-PLOR NIH	2.36	Bruker Biospin
5	structure validation	X-PLOR NIH	2.36	Bruker Biospin
6	processing	X-PLOR NIH	2.36	Goddard
7	chemical shift assignment	X-PLOR NIH	2.36	Goddard
8	data analysis	X-PLOR NIH	2.36	Goddard
9	refinement	X-PLOR NIH	2.36	Goddard
10	structure validation	X-PLOR NIH	2.36	Goddard
11	processing	X-PLOR NIH	2.36	Cornilescu, Delaglio and Bax
12	chemical shift assignment	X-PLOR NIH	2.36	Cornilescu, Delaglio and Bax
13	data analysis	X-PLOR NIH	2.36	Cornilescu, Delaglio and Bax
14	refinement	X-PLOR NIH	2.36	Cornilescu, Delaglio and Bax
15	structure validation	X-PLOR NIH	2.36	Cornilescu, Delaglio and Bax
16	processing	X-PLOR NIH	2.36	Schwieters, Kuszewski, Tjandra and Clore
17	chemical shift assignment	X-PLOR NIH	2.36	Schwieters, Kuszewski, Tjandra and Clore
18	data analysis	X-PLOR NIH	2.36	Schwieters, Kuszewski, Tjandra and Clore
19	refinement	X-PLOR NIH	2.36	Schwieters, Kuszewski, Tjandra and Clore
20	structure validation	X-PLOR NIH	2.36	Schwieters, Kuszewski, Tjandra and Clore
21	processing	X-PLOR NIH	2.36	Bhattacharya and Montelione
22	chemical shift assignment	X-PLOR NIH	2.36	Bhattacharya and Montelione
23	data analysis	X-PLOR NIH	2.36	Bhattacharya and Montelione
24	refinement	X-PLOR NIH	2.36	Bhattacharya and Montelione
25	structure validation	X-PLOR NIH	2.36	Bhattacharya and Montelione

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.

Prepare Data

Validate Data

Deposit Data

Help and Resources

2MSG

Solid-state NMR structure of ubiquitin